Search

Search Constraints

You searched for: Author/Creator Buisson, Anthony

Search Results

1. A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease. Issue 5 (22nd December 2019)

2. Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's Disease. (12th January 2022)

3. Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes. Issue 41 (October 2016)

4. Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes. Issue 41 (October 2016)

5. Association of Adherent-invasive Escherichia coli with severe Gut Mucosal dysbiosis in Hong Kong Chinese population with Crohn's disease. (1st January 2021)

6. Clinical guidelines for the management of inflammatory bowel disease: Update of a French national consensus. Issue 1 (January 2021)

7. Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease. Issue 8 (24th May 2017)

8. Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease. Issue 8 (August 2017)

9. Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study. (2nd December 2022)

10. Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy. Issue 12 (28th April 2021)